Incyte announces FDA approval for Zynyz™
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read Details
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset Pompe Disease. We applaud Amicus and are proud to have contributed to their cold chain over the last seven years with full validation master planning and transport simulation.
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read DetailsThe team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...
read DetailsThe team at Atara Biotherapeutics announced EU Approval on their allogeneic T-cell therapy to treat adult...
read Details